into HPMC capsules to match the CRD-4730 active capsules in appearance clinical trials

A PHASE 2A, INVESTIGATOR AND SUBJECT BLINDED, SPONSOR UNBLINDED, PLACEBO-CONTROLLED, CLINICAL STUDY TO EVALUATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS, AND PHARMACODYNAMICS OF CRD-4730 IN PARTICIPANTS WITH CATECHOLAMINERGIC POLYMORPHIC VENTRICULAR TACHYCARDIA

This study is looking at a new medicine called CRD-4730 for people with a heart condition called CPVT. It's an early-stage trial trying to find out if the medicine is safe and how it affects the body.